Senegal vs Zambia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Senegal
0.4%
in 2024
Zambia
0.4%
in 2024
Senegal rank
59th
Zambia rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Senegal
- Zambia
How they compare
Senegal currently reports 0.4% against 0.4% in Zambia, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Senegal ahead.
Senegal ranks 59th and Zambia ranks 59th of 215 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Senegal | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 0.6% | 0.3% | Senegal |
| 2020s | 0.5% | 0.4% | 0.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Senegal or Zambia?
- Senegal, at 0.4% against 0.4% in Zambia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Senegal and Zambia?
- 0.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Zambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Senegal and Zambia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Senegal ranks 59th and Zambia ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.